Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Assets Average (2016 - 2025)

Ocular Therapeutix has reported Assets Average over the past 12 years, most recently at $609.5 million for Q4 2025.

  • Quarterly results put Assets Average at $609.5 million for Q4 2025, up 28.54% from a year ago — trailing twelve months through Dec 2025 was $609.5 million (up 28.54% YoY), and the annual figure for FY2025 was $633.0 million, up 78.31%.
  • Assets Average for Q4 2025 was $609.5 million at Ocular Therapeutix, up from $431.1 million in the prior quarter.
  • Over the last five years, Assets Average for OCUL hit a ceiling of $609.5 million in Q4 2025 and a floor of $125.6 million in Q2 2023.
  • Median Assets Average over the past 5 years was $230.5 million (2021), compared with a mean of $301.9 million.
  • Biggest five-year swings in Assets Average: tumbled 30.38% in 2023 and later skyrocketed 320.51% in 2024.
  • Ocular Therapeutix's Assets Average stood at $211.3 million in 2021, then fell by 27.15% to $153.9 million in 2022, then soared by 34.62% to $207.2 million in 2023, then soared by 128.81% to $474.2 million in 2024, then increased by 28.54% to $609.5 million in 2025.
  • The last three reported values for Assets Average were $609.5 million (Q4 2025), $431.1 million (Q3 2025), and $428.6 million (Q2 2025) per Business Quant data.